Tersera Therapeutics
VARUBI
Manufacturer:
Tersera Therapeutics
Name:
VARUBI
HCPCS Code Descriptor:
Rolapitant, oral, 1 mg
Category:
J Code
HCPCS:
J8670
NDC(s):
70720-0101-02
Primary Type:
Oncology-Anti-Emetic
Generic Status:
Single-Source
Route of Administration:
Oral
About:
VARUBI is an Oncology-Anti-Emetic drug manufactured by Tersera Therapeutics and administered via the Oral route of administration. The J Code: J8670 is aligned to the drug VARUBI.